Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?
Laszlo D, Pruneri G, Andreola G, Radice D, Calabrese L, Rafaniello PR, Nassi L, Sammassimo S, Alietti A, Agazzi A, Vanazzi A, Martinelli G. Laszlo D, et al. Among authors: vanazzi a. Int J Surg Pathol. 2011 Aug;19(4):417-24. doi: 10.1177/1066896909345596. Epub 2009 Sep 30. Int J Surg Pathol. 2011. PMID: 19793830
Cerebrospinal fluid diffusion of Zevalin after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement.
Ferrucci PF, Vanazzi A, Tesoriere G, Ferrari M, Bartolomei M, Rocca P, Cremonesi M, Paganelli G, Martinelli G. Ferrucci PF, et al. Among authors: vanazzi a. Ann Oncol. 2005 Oct;16(10):1710-1. doi: 10.1093/annonc/mdi305. Epub 2005 Jun 21. Ann Oncol. 2005. PMID: 15972281 Free article. No abstract available.
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
Ferrucci PF, Vanazzi A, Grana CM, Cremonesi M, Bartolomei M, Chinol M, Ferrari M, Radice D, Papi S, Martinelli G, Paganelli G. Ferrucci PF, et al. Among authors: vanazzi a. Br J Haematol. 2007 Nov;139(4):590-9. doi: 10.1111/j.1365-2141.2007.06869.x. Br J Haematol. 2007. PMID: 17979944 Free article.
Rituximab in Hodgkin lymphoma: is the target always a hit?
Saini KS, Azim HA Jr, Cocorocchio E, Vanazzi A, Saini ML, Raviele PR, Pruneri G, Peccatori FA. Saini KS, et al. Among authors: vanazzi a. Cancer Treat Rev. 2011 Aug;37(5):385-90. doi: 10.1016/j.ctrv.2010.11.005. Epub 2010 Dec 22. Cancer Treat Rev. 2011. PMID: 21183282 Review.
35 results